TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 9.38
-0.09 (-0.90%)
Sep 11, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 3.86 billion as of September 11, 2026. Its market cap has decreased by -89.20% in one year.
Market Cap
3.86B
Enterprise Value
2.80B
Revenue
40.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.38
ChartMarket Cap Chart
Since June 23, 2025, HKG:2617's market cap has decreased from 9.33B to 3.86B, a decrease of -58.63%. That is a compound annual growth rate of -51.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 3.86B | -91.54% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 5.38B |
| Shanghai Bao Pharmaceuticals | 5.21B |
| Jacobio Pharmaceuticals Group | 4.79B |
| Ocumension Therapeutics | 4.33B |
| Hanx Biopharmaceuticals (Wuhan) | 3.96B |
| Qyuns Therapeutics | 3.69B |
| Mirxes Holding Company | 3.66B |
| HJ Science | 3.17B |